Diagnosis of Paget disease outside of the breast is a dubious disease in the field of autoimmunity and rheumatic immunity, clinical performance is complex and often involves multi-system fatigue. Early identification and standardized clinical care are essential for improving prognosis. Diagnosis of Paget disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many autoimmune and rheumatic immune disorders that were previously difficult to treat have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to timely schemes according to changes in conditions.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of non-breast Paget disease. The platform serves a team of internationally authoritative experts in the field of autoimmune and rheumatic immunity within the Chinese international medical service system, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.